1308380-46-2

Upstream product

• 1308380-43-9 {(R)-2-[5-(2-chloro-acetylamino)-3-(2,6-difluoro-benzyl)-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethyl}-carbamic acid tert-butyl ester 
• 1308380-42-8 {(R)-2-[5-amino-3-(2,6-difluoro-benzyl)-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethyl}-carbamic acid tert-butyl ester 
• 1308380-39-3 {(R)-2-[3-(2,6-difluoro-benzyl)-5-nitro-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethyl}-carbamic acid tert-butyl ester 
• 1080433-46-0 1-(2,6-difluoro-benzyl)-5-nitro-1H-pyrimidine-2,4-dione 
• 85118-00-9 2,6-Difluorobenzyl bromide 
• 1308380-45-1 ((R)-2-{3-(2,6-difluoro-benzyl)-5-[2-(2-hydroxy-ethylamino)-acetylamino]-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-1-phenyl-ethyl)-carbamic acid tert-butyl ester 

Downstream Products

• 1308378-76-8 3-((R)-2-amino-2-phenyl-ethyl)-5-(4-benzyl-2-oxo-piperazin-1-yl)-1-(2,6-difluoro-benzyl)-1H-pyrimidine-2,4-dione 

Relevant academic research and scientific papers

Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same

Disclosed are compounds useful as gonadotrophin-releasing hormone (“GnRH”) receptor antagonist.

GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS, MANUFACTURING METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

Disclosed are compounds useful as gonadotropin-releasing hormone ("GnRH") receptor antagonist.